Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Dacomitinib for Metastatic Non-Small Cell Lung Cancer

americanpharmaceuticalreviewSeptember 29, 2018

Tag: FDA , Metastatic Non-Small , cancer

PharmaSources Customer Service